TipRanks
Go Ultimate55% OFF

Compare NanoViricides (NV3P) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NV3PNanoViricidesEUR 1.18EUR 30.30M-3.23-16.90%Moderate BuyDE:NV3P
ENLVEnlivex$1.78$2.73M0.00-99.29%Moderate BuyDE:NV3P vs ENLV
AKTXAkari Therapeutics$8.24$14.42M-0.01-71.79%Strong BuyDE:NV3P vs AKTX
MBRXMoleculin Biotech$7.90$8.29M-0.02-96.50%Strong BuyDE:NV3P vs MBRX
SABSSAB Biotherapeutics$3.35$304.80M0.9411.30%Strong BuyDE:NV3P vs SABS

Performance Comparison

-100%-75%-50%-25%0%25%50%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NV3PNanoViricides1.18-0.18-13.24%
ENLVEnlivex1.78-250.22-99.29%
AKTXAkari Therapeutics8.24-20.76-71.59%
MBRXMoleculin Biotech7.90-251.95-96.96%
SABSSAB Biotherapeutics3.350.103.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts